NCT01849835

Brief Summary

The purpose of this randomized controlled trial (RCT) is to compare the two ways (tras-rectal and trans-perineal) to perform prostate biopsy from the rate of Positive detection, complications, pain level, operation time and costs et al.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2013

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 9, 2013

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
Last Updated

May 6, 2014

Status Verified

May 1, 2014

Enrollment Period

1.9 years

First QC Date

April 29, 2013

Last Update Submit

May 4, 2014

Conditions

Keywords

rate of positive detection

Outcome Measures

Primary Outcomes (1)

  • the rate of positive detections

    1year

Secondary Outcomes (1)

  • the incidence rate of each complication

    1 year

Other Outcomes (1)

  • pain level assessed by visual analogue scale

    1 year

Study Arms (2)

trans-rectal

EXPERIMENTAL

trans-rectal to perform the prostate biopsy

Procedure: trans-rectal to perform the prostate biopsy

trans-perineal

EXPERIMENTAL

trans-perineal to perform the prostate biopsy

Procedure: trans-perineal to perform the prostate biopsy

Interventions

the puncture points are at the rectal

trans-rectal

the puncture points are at the perineal

Also known as: the puncture points are at the perineal
trans-perineal

Eligibility Criteria

AgeUp to 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • prostate-specific antigen \> 4ng/ml
  • Palpation is positive

You may not qualify if:

  • older than 80y
  • prostate-specific antigen \> 100 ng/ml

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

10Th Hospital of Tongji University

Shanghai, Shanghai Municipality, 200072, China

RECRUITING

Related Publications (1)

  • Evidence-based Guidelines for Best Practice in Health Care Transrectal Ultrasound Guided Biopsy of the Prostate

    BACKGROUND

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 29, 2013

First Posted

May 9, 2013

Study Start

January 1, 2013

Primary Completion

December 1, 2014

Last Updated

May 6, 2014

Record last verified: 2014-05

Locations